Antigens and hepatitis

J. Pedreira; J. Guardia; J. M. Martinez Vasquez

Antigens and hepatitis

J. Pedreira, J. Guardia, J. M. Martinez Vasquez

Department of Medicine

Research output: Contribution to journal › Article › Research › peer-review

Abstract

HAAg (hepatitis A antigen) allows the differentiation of the virus A hepatitis from the HBAg-positive cases, and it will help in the study of evolution and prognosis of this type of hepatitis. HBsAg is a marker of viral hepatitis, and its persistence suggests chronicity in patients with previous acute hepatitis. Nonparenteral transmission of HBV seems likely, in view of what is known about HBAg. Studies of the core antigen and antibody are beginning; their clinical application does not seem important so far. The presence of e-antigen acts as a faithful marker of HBsAg hepatitis development.

Original language	English
Pages (from-to)	16-19
Journal	Comprehensive Therapy
Volume	3
Issue number	7
Publication status	Published - 1 Dec 1977

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{a1c4e45db7054032bf2115770d6d5829,

title = "Antigens and hepatitis",

abstract = "HAAg (hepatitis A antigen) allows the differentiation of the virus A hepatitis from the HBAg-positive cases, and it will help in the study of evolution and prognosis of this type of hepatitis. HBsAg is a marker of viral hepatitis, and its persistence suggests chronicity in patients with previous acute hepatitis. Nonparenteral transmission of HBV seems likely, in view of what is known about HBAg. Studies of the core antigen and antibody are beginning; their clinical application does not seem important so far. The presence of e-antigen acts as a faithful marker of HBsAg hepatitis development.",

author = "J. Pedreira and J. Guardia and \{Martinez Vasquez\}, \{J. M.\}",

year = "1977",

month = dec,

day = "1",

language = "English",

volume = "3",

pages = "16--19",

journal = "Comprehensive Therapy",

issn = "0098-8243",

publisher = "Humana Press Inc.",

number = "7",

}

TY - JOUR

T1 - Antigens and hepatitis

AU - Pedreira, J.

AU - Guardia, J.

AU - Martinez Vasquez, J. M.

PY - 1977/12/1

Y1 - 1977/12/1

N2 - HAAg (hepatitis A antigen) allows the differentiation of the virus A hepatitis from the HBAg-positive cases, and it will help in the study of evolution and prognosis of this type of hepatitis. HBsAg is a marker of viral hepatitis, and its persistence suggests chronicity in patients with previous acute hepatitis. Nonparenteral transmission of HBV seems likely, in view of what is known about HBAg. Studies of the core antigen and antibody are beginning; their clinical application does not seem important so far. The presence of e-antigen acts as a faithful marker of HBsAg hepatitis development.

AB - HAAg (hepatitis A antigen) allows the differentiation of the virus A hepatitis from the HBAg-positive cases, and it will help in the study of evolution and prognosis of this type of hepatitis. HBsAg is a marker of viral hepatitis, and its persistence suggests chronicity in patients with previous acute hepatitis. Nonparenteral transmission of HBV seems likely, in view of what is known about HBAg. Studies of the core antigen and antibody are beginning; their clinical application does not seem important so far. The presence of e-antigen acts as a faithful marker of HBsAg hepatitis development.

UR - https://www.scopus.com/pages/publications/0017646181

M3 - Article

SN - 0098-8243

VL - 3

SP - 16

EP - 19

JO - Comprehensive Therapy

JF - Comprehensive Therapy

IS - 7

ER -

Antigens and hepatitis

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this